HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marta Grodzik Selected Research

Graphite

1/2021Reduced Graphene Oxides Modulate the Expression of Cell Receptors and Voltage-Dependent Ion Channel Genes of Glioblastoma Multiforme.
8/2020Effect of Graphene Family Materials on Multiple Myeloma and Non-Hodgkin's Lymphoma Cell Lines.
12/2019Use of Selected Carbon Nanoparticles as Melittin Carriers for MCF-7 and MDA-MB-231 Human Breast Cancer Cells.
2/2019Degradation of Mitochondria and Oxidative Stress as the Main Mechanism of Toxicity of Pristine Graphene on U87 Glioblastoma Cells and Tumors and HS-5 Cells.
1/2019Graphene oxide down-regulates genes of the oxidative phosphorylation complexes in a glioblastoma.
12/2018Effects of Reduced Graphene Oxides on Apoptosis and Cell Cycle of Glioblastoma Multiforme.
10/2018NF-κB-related decrease of glioma angiogenic potential by graphite nanoparticles and graphene oxide nanoplatelets.
9/2017Interaction of different forms of graphene with chicken embryo red blood cells.
1/2017Diamond, graphite, and graphene oxide nanoparticles decrease migration and invasiveness in glioblastoma cell lines by impairing extracellular adhesion.
10/2016Toxicity of different forms of graphene in a chicken embryo model.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marta Grodzik Research Topics

Disease

16Neoplasms (Cancer)
12/2019 - 01/2011
14Glioblastoma (Glioblastoma Multiforme)
01/2021 - 01/2011
8Glioma (Gliomas)
01/2021 - 01/2013
5Infections
03/2022 - 10/2019
3Brain Neoplasms (Brain Tumor)
10/2017 - 01/2011
2Acanthamoeba Keratitis
05/2021 - 05/2020
2Necrosis
12/2019 - 01/2013
2Breast Neoplasms (Breast Cancer)
12/2019 - 03/2019
2Liver Neoplasms (Liver Cancer)
03/2019 - 01/2016
2Colorectal Neoplasms (Colorectal Cancer)
03/2019 - 04/2018
2Body Weight (Weight, Body)
10/2016 - 12/2015
1Cysts
12/2020
1Multiple Myeloma
08/2020
1Non-Hodgkin Lymphoma (Lymphosarcoma)
08/2020
1Hematologic Neoplasms (Hematological Malignancy)
08/2020
1Hepatocellular Carcinoma (Hepatoma)
12/2019
1Poxviridae Infections
10/2019
1Bacterial Infections (Bacterial Infection)
10/2019
1Adenocarcinoma
03/2019
1Drug-Related Side Effects and Adverse Reactions
10/2017
1Hemolysis
09/2017
1type 2 alpha 1 Collagenopathy
01/2015
1Starvation
02/2008

Drug/Important Bio-Agent (IBA)

13GraphiteIBA
01/2021 - 01/2013
9graphene oxideIBA
01/2021 - 01/2015
8Proteins (Proteins, Gene)FDA Link
12/2019 - 02/2008
4SilverIBA
05/2021 - 01/2015
4OxidesIBA
01/2021 - 12/2018
4CarbonIBA
12/2019 - 01/2011
4DiamondIBA
12/2019 - 01/2016
3Messenger RNA (mRNA)IBA
12/2019 - 10/2017
2Contact Lens Solutions (Contact Lens Solution)IBA
05/2021 - 12/2020
2PlatinumIBA
03/2019 - 10/2017
2Reactive Oxygen Species (Oxygen Radicals)IBA
10/2018 - 01/2017
2Proliferating Cell Nuclear Antigen (PCNA)IBA
10/2017 - 01/2017
2Cisplatin (Platino)FDA LinkGeneric
10/2017 - 01/2017
1Ion Channels (Ion Channel)IBA
01/2021
1Bee Venoms (Bee Venom)IBA
12/2019
1Melitten (Melittin)IBA
12/2019
1Cytochrome P-450 CYP2C9IBA
12/2019
1chenodeoxycholate sulfate conjugate (CDCS)IBA
10/2019
1Cathepsin BIBA
10/2019
1CathepsinsIBA
10/2019
1CystatinsIBA
10/2019
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
10/2019
1Cystatin BIBA
10/2019
1Cathepsin LIBA
10/2019
1diazonaphthalenedisulfonic acid (NDS)IBA
04/2019
1CyclinsIBA
04/2019
1EnzymesIBA
03/2019
1Bromodeoxyuridine (BrdU)IBA
03/2019
1SaltsIBA
03/2019
1Pharmaceutical PreparationsIBA
03/2019
1Oxygen (Dioxygen)IBA
12/2018
1Interleukin-8 (Interleukin 8)IBA
10/2018
1Transcription Factors (Transcription Factor)IBA
10/2018
1Interleukin-6 (Interleukin 6)IBA
10/2018
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
10/2018
1Reactive Nitrogen SpeciesIBA
10/2018
1AntioxidantsIBA
04/2018
1Biological ProductsIBA
10/2017
1Caspase 3 (Caspase-3)IBA
10/2017
1DNA (Deoxyribonucleic Acid)IBA
01/2017
1CateninsIBA
01/2017
1Antineoplastic Agents (Antineoplastics)IBA
01/2016
1CurcuminIBA
01/2016
1Proline (L-Proline)FDA Link
10/2015
1Arginine (L-Arginine)FDA Link
10/2015
1Hydroxyproline (4 Hydroxyproline)IBA
01/2015
1NitrogenIBA
02/2008

Therapy/Procedure

7Therapeutics
12/2018 - 01/2013
3Contact Lenses
05/2021 - 05/2020
1Immunotherapy
03/2022
1Aftercare (After-Treatment)
01/2021
1Injections
09/2017
1Intraperitoneal Injections
12/2015
1Protein-Restricted Diet (Diet, Protein Restricted)
02/2008